Observational studyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2026
Medicaid Expansion and Optimal Starts of Treatment for Incident Kidney Failure.
Observational study in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
RATIONALE &
objectiveBeginning in 2014, some states expanded Medicaid eligibility to include additional low-income adults under the age of 65 years. Examining whether the expansion led to improvements in optimal treatment at the start of kidney failure has been understudied and was the focus of this investigation. STUDY
designObservational cohort study. SETTING &
participantsPatients aged 26-64 years represented in the US Renal Data System initiating treatment for kidney failure between 2008 and 2019. EXPOSURE: Residence in states that did or did not expand Medicaid in 2014. OUTCOME: An optimal start of kidney failure treatment was defined as undergoing preemptive kidney transplant, initiating home dialysis, or initiating in-center hemodialysis using an arteriovenous access. ANALYTICAL APPROACH: Interrupted time-series analyses were implemented to evaluate the adjusted association of residence in a Medicaid-expansion state and optimal kidney failure treatment by comparing the trend in optimal kidney failure treatment starts during the preexpansion period versus the postexpansion period.
resultsBefore Medicaid expansion, the percentage of patients with optimal starts increased similarly in expansion and nonexpansion states. After Medicaid expansion, the percentage with optimal starts continued to increase in expansion states but decreased in nonexpansion states, resulting in a 3.9% (95% CI, 0.5%-7.2%) higher percentage with optimal starts in expansion versus nonexpansion states by 2019 (postexpansion vs preexpansion change in trend, P = 0.02). Most of the change in trend was attributable to a greater increase in use of home dialysis at initiation of kidney failure treatment in expansion versus nonexpansion states (difference of 0.29% per year; 95% CI, 0.08%-0.51%) during the postexpansion period. LIMITATIONS: Potential for unmeasured confounding from state-level factors other than Medicaid expansion.
conclusionsMedicaid expansion was associated with an increasing percentage of patients with incident kidney failure experiencing an optimal start to treatment, driven mostly by an increase in the use of home dialysis. Expanding Medicaid coverage may offer an opportunity to improve treatment for low-income patients initiating kidney replacement therapy. PLAIN-LANGUAGE SUMMARY: This study examined whether the expansion of Medicaid eligibility in 2014 led to improvements in the percentage of patients receiving an optimal start to treatment for new-onset kidney failure (ie, kidney transplant before the need to start dialysis, initiation of home dialysis, or initiation of in-center hemodialysis using an arteriovenous access). We compared trends from 2008 to 2019 across US states that expanded Medicaid and those that did not. Before 2014, both groups showed a similar upward trend in optimal starts. However, after Medicaid expansion, states that expanded Medicaid continued to experience an increase in optimal starts whereas states that did not expand showed a decrease over time. Much of the difference was explained by a larger increase in the use of home dialysis in states that expanded access to Medicaid. Our findings suggest that expanding Medicaid may lead to better initial treatment for kidney failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.